Thursday, August 27, 2015

Pharma facts 2012: Health Care is the Real Fiscal Cliff

All this week Check Up will be sharing one new Pharma fact a day that was an important breakthrough in the world of pharmaceuticals in 2012. Today, Check Up delves into the worries of the new health care.

Pharma facts 2012: Health Care is the Real Fiscal Cliff

0 comments

Editor’s Note: All this week Check Up will be sharing one new Pharma fact a day that was an important breakthrough in the world of pharmaceuticals in 2012. Today, Check Up delves into the worries of the new health care.

Health care costs already devour 18% of America's GDP.  Between now and 2030 a cohort of 76 million baby boomers will become elderly, thereby driving health costs through the roof.  Budget actuaries see this escalation of health care costs as the principal reason why they expect the federal budget deficit to grow out of control.

The Affordable Care Act won't do much, if anything, to control rising costs.  Health insurers and pharma will derive the largest, most direct benefit from the ACA because it requires everyone to buy health insurance and, as a result, it makes 32 million more Americans buyers of prescription drugs (see here).  Pharma companies know the incremental sales volume from these new customers will return to them many times more than the $80 billion in fees they will pay to shrink the donut hole.

It is well known that America maintains an unmanaged, patchwork health system that stands as the most expensive and least effective in the developed world.  Right now, for example, the US spends 30% more on administration than on actual health care delivery.  But there is also an interesting corollary to this shameful situation that might shock reactionaries, rural physicians, pharma flacks and other proponents of the current system.  The fact that Americans pay higher drug prices, for example, coupled with increasingly aggressive price controls in Europe, means the US is subsidizing the rest of the world.  Your-on-your-own Republicans who don't want to pay for someone else's health care would grow enraged if they realized their $70 co-pay at the pharmacy supports day care, unemployment benefits and other nanny-state measures across western Europe.

-          Dan Hoffman

President, Pharmaceutical Business Research Associates
0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog

Check Up is a blog for savvy health consumers, covering the latest developments, discoveries, and debates from the Philadelphia area and beyond.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Charlotte Sutton Health and Science Editor, Philadelphia Inquirer
Tom Avril Inquirer Staff Writer, heart health and general science
Stacey Burling Inquirer Staff Writer, nueroscience and ageing
Marie McCullough Inquirer Staff Writer, cancer and women's health
Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Hooman Noorchashm, M.D., Ph.D. Cardiothoracic surgeon in the Philadelphia area
Amy J. Reed, M.D., Ph.D. Anesthesiologist and Surgical Intensivist in the Philadelphia Area
Latest Health Videos
Also on Philly.com:
letter icon Newsletter